Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice

被引：12

作者：

Simeoli, Raffaele ^{[1
]}

Dorlo, Thomas P. C. ^{[2
]}

Hanff, Lidwien M. ^{[3
]}

Huitema, Alwin D. R. ^{[2
,3
,4
]}

Dreesen, Erwin ^{[5
]}

机构：

[1] Bambino Gesu Pediat Hosp, Div Metab Dis & Drug Biol, IRCCS, Rome, Italy

[2] Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands

[3] Princess Maxima Ctr Pediat Oncol, Dept Pharmacol, Utrecht, Netherlands

[4] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands

[5] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Clin Pharmacol & Pharmacotherapy Unit, Leuven, Belgium

来源：

FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷

关键词：

therapeutic drug monitoring; pediatrics; pharmacokinetic; pharmacodynamics; antimicrobials; personalized therapy; PRETERM;

D O I：

10.3389/fphar.2022.931843

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：4

共 50 条

[11] Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study [J].

Escudero-Ortiz, Vanesa ;

Dominguez-Lenero, Vanessa ;

Catalan-Latorre, Ana ;

Rebollo-Liceaga, Joseba ;

Sureda, Manuel .

PHARMACEUTICS, 2022, 14 (06)

[12] Therapeutic drug monitoring: applying the 'Goldilocks Principle' to clinical pharmacology [J].

Penson, Peter E. ;

McCloskey, Alice P. .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (08) :685-686

[13] Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients [J].

Schoenenberger-Arnaiz, Joan Antoni ;

Ahmad-Diaz, Faten ;

Miralbes-Torner, Mar ;

Aragones-Eroles, Ana ;

Cano-Marron, Manuel ;

Palomar-Martinez, Mercedes .

EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (E1) :E30-E35

[14] Clinical value of therapeutic drug monitoring for levetiracetam in pediatric patients with epilepsy [J].

Yamamoto, Yoshiaki ;

Ohta, Akiko ;

Usui, Naotaka ;

Imai, Katsumi ;

Kagawa, Yoshiyuki ;

Takahashi, Yukitoshi .

BRAIN & DEVELOPMENT, 2023, 45 (05) :285-292

[15] Therapeutic drug monitoring of inununosuppressant drugs in clinical practice [J].

Kahan, BD ;

Keown, P ;

Levy, GA ;

Johnston, A .

CLINICAL THERAPEUTICS, 2002, 24 (03) :330-350

[16] Vancomycin Therapeutic Drug Monitoring (TDM) and Its Association with Clinical Outcomes: A Retrospective Cohort [J].

Al-Maqbali, Juhaina Salim ;

Al Shukri, Zahra ;

Al Sabahi, Nawf ;

AL-Riyami, Intisar ;

Al Alawi, Abdullah M. .

JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (05) :589-593

[17] Therapeutic drug monitoring is a useful tool for a sub-set of patients with tuberculosis [J].

不详 .

Drugs & Therapy Perspectives, 2003, 19 (8) :13-16

[18] Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations [J].

Martson, Anne-Grete ;

Veringa, Anette ;

van den Heuvel, Edwin R. ;

Bakker, Martijn ;

Touw, Daan J. ;

van der Werf, Tjip S. ;

Span, Lambert F. R. ;

Alffenaar, Jan-Willem C. .

MYCOSES, 2019, 62 (08) :698-705

[19] Therapeutic Drug Monitoring: Appropriateness and Clinical Utility in Neuropsychiatry Practice [J].

Sharma, Sangeeta ;

Joshi, Sukriti ;

Mukherji, Shoma ;

Bala, Kiran ;

Tripathi, C. B. .

AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (01) :11-16

[20] Individual clearance and therapeutic drug monitoring of Quetiapine in clinical practice [J].

Wittmann, Markus ;

Hausner, Helmut ;

Koestlbacher, Anton ;

Hajak, Goran ;

Haen, Ekkehard .

NEUROENDOCRINOLOGY LETTERS, 2010, 31 (02) :203-207

← 1 2 3 4 5 →